Published On: June 30th, 2011
A special advisory committee of the Food and Drug Administration voted 6-0 Wednesday that approval of the drug Avastin as a breast-cancer treatment should be revoked, handing a defeat to Avastin maker Roche. Peter Landers has details from Washington.

Read more here:
News Hub: Panel Deals Blow to Breast-Cancer Drug/a>
Loading...
Leave a comment



Did you know:





